Medline Industries, LP 2026-06-03 Health critical FDA
Health · FDA · Recall #FDA-Z-2234-2026
Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as:… Recall
Issued June 3, 2026 · Medline Industries, LP
In June 2026, Medline Industries, LP recalled the Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as:…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.
What you should do
- 1 Stop using Medline kits containing Huons Co. Bupivacaine HCL in Dextrose Injection, USP, labeled as:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Medline Industries, LP to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Medline Industries, LP
- Category
- Health
- Recall date
- June 3, 2026
- Units affected
- Not reported
- Sold at
- Worldwide - US Nationwide distribution in the US Territory of Virgin Islands and the countries of Bahamas, Panama, Barbados.
- Recall number
- FDA-Z-2234-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Medline Industries, LP has 50 recalls in our database, including 8 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.